Cutaneous infection with Mycobacterium gordonae |
| |
| Authors: | P McIntyre Z Blacklock J G McCormack |
| |
| Affiliation: | 2. Tuberculosis Laboratory, Laboratory of Microbiology and Pathology, Brisbane, Australia;3. Department of Medicine, University of Queensland, Mater Hospital, Brisbane, Australia;1. Pulmonary/Critical Care Service, Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX 78234, United States;2. U.S. Army Institute of Surgical Research, JBSA Fort Sam Houston, TX 78234-6315, United States;3. Department of Radiology, Brooke Army Medical Center, JBSA Fort Sam Houston, TX 78234, United States;4. Department of Clinical Investigation, Brooke Army Medical Center, JBSA Fort Sam Houston, TX 78234, United States;1. Department of Veterans Affairs (VA), Spinal Cord Injury Quality Enhancement Research Initiative (SCI QUERI), Edward Hines Jr. VA Hospital, Hines, IL, USA;2. Center of Innovation for Complex Chronic Health Care (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA;3. Center for Evaluation of Practices and Experiences of Patient-Centered Care (CEPEP), Edward Hines Jr. VA Hospital, Hines, IL, USA;4. Center for Healthcare Studies, Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA;5. Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University, Chicago, IL, USA;1. Dept. of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen Ø, Denmark;2. Dept. of Otorhinolaryngology, Parirenyatwa Hospital, Mazove Street, Harare, Zimbabwe |
| |
| Abstract: | A case of cutaneous infection with Mycobacterium gordonae and other reports of extrapulmonary infection due to this organism are reviewed. This case confirms the pathogenic potential of M. gordonae which must now be included among the scotochromogens capable of causing cutaneous disease. Isolates of this organism should be tested against a full range of antimicrobial agents since traditional antituberculous therapy may be of limited efficacy. Pending the results of in vitro susceptibility testing, amikacin, ethambutol, rifampicin and co-trimoxazole are suggested as empirical therapy for infections caused by this organism. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
